Sp2 transcription factor (SP2)

Sp2 transcription factor is a sequence-specific DNA-binding protein and a member of the Sp subfamily within the Sp/XKLF (Kruppel-like factor) transcription factor family[1][2][3][5]. It contains three C-terminal zinc finger motifs and a unique, less-conserved DNA-binding domain that sets it apart from other Sp family members[1][3]. Sp2 localizes mainly to subnuclear foci associated with the nuclear matrix and is involved in regulating the expression of a wide variety of essential genes, often by binding GC-rich promoter elements[1][2][3][4]. It can function as both a transcriptional activator and repressor depending on the target gene and cellular context[1][2][3]. Sp2 plays a key role in cell proliferation, metabolism (notably repressing genes in the cholesterol synthesis pathway), and development; knockout studies show that it is essential for early embryonic development in mice[2][4]. In the immune system, Sp2 helps regulate the Th17 phenotype and cytokine signaling[1]. It has been implicated in pathological settings such as cancer progression (e.g., hepatocellular carcinoma) and vascular calcification, as well as astrocyte proliferation following central nervous system injury[1]. Despite these roles, Sp2 is not currently considered a direct therapeutic target (i.e., there are no drugs targeting Sp2 in clinical use or advanced study)[1][2][3][5].

Other names

Sp2SP24930480I16RikmKIAA0048